Clinical Trial Update: A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study comparing clindamycin phosphate vaginal cream 2% to Clindesse and to placebo in non-pregnant women with bacterial vagin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• CLINDESSE (CLINDAMYCIN PHOSPHATE)
• Clindamycin phosphate vaginal cream 2% (clindamycin phosphate)

Snippet

Sponsor: Actavis Inc. | Conditions: BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include | Phase 3 | Status: COMPLETED | Results posted: 2019-12-26